Your gift today will accelerate cancer research to help improve prevention, detection, and treatment for all types of cancer.
About the National Foundation For Cancer Research
NFCR provides scientists in the labs the funding they need to make game-changing discoveries in cancer treatments, detection, prevention, and, ultimately, a cure for all types of cancer.
Our Goal and Approach
- We are one of few charities willing to take risks and fund the most innovative ideas in cancer research.
- We understand the critical unmet needs of cancer patients and support the forefront of new cancer research ideas.
Together, we can make cancer history.
A Cancer Research Charity You Can Trust
NFCR Certified as one of America’s Best Charities
The National Foundation for Cancer Research (NFCR) has earned certification by America’s Best Charities, a respected federation that annually screens and affirms nonprofits meeting rigorous standards of accountability, transparency, and program effectiveness. This certification signifies that NFCR is recognized among a select group of top U.S. charities that donors can trust to use their contributions responsibly and make a meaningful impact. As a certified member, NFCR is included in workplace giving campaigns and donor outreach efforts that connect generous contributors with high-quality organizations doing important work — giving supporters added confidence that their gifts help advance critical cancer research.

The National Foundation for Cancer Research offers the latest news and information in cancer research, treatment, prevention and education. We encourage you to sign-up to explore our newsletter articles, blog posts, survivor stories, local events and more.
Cancer impacts everyone—whether you’re a patient, caregiver, advocate, or researcher — This podcast delivers invaluable insights from those on the frontlines of the fight against it. Listen Now to NFCR’s Podcast All Things Cancer.

#19
FEATURING: Dr. Tony Hunter on the Accidental Discovery that Changed Cancer Treatment
While studying tumor viruses at the Salk Institute, Dr. Hunter discovered tyrosine phosphorylation — a process by which rogue enzymes drive abnormal cell growth. It was an accidental finding that quietly set off a revolution. Today, it underpins more than 80 FDA-approved cancer drugs, including the landmark therapy Gleevec.
Testimonials
How to Get Involved
Join Our Mailing List


















